Stay Updated
Press Releases
WASHINGTON, DC — While COVID-19 has claimed more than 110,000 American lives, it’s business as usual for Wall Street and Big Pharma. In a new blog post, Patients For Affordable Drugs examines how drug corporations and Wall Street together push for high prices on COVID-19 treatments and vaccines developed with taxpayer support. The piece looks […]
Press Releases
U.S. Taxpayers Are Mega-Funders in Promising COVID-19 Vaccine
WASHINGTON, DC — The growing crisis around COVID-19 brings into stark view America’s broken drug pricing system. Currently, U.S. taxpayers are contributing up to $483 million in support of a COVID-19 vaccine from Moderna Therapeutics. In a blog published today, Patients For Affordable Drugs argues that as partners funding the science, development, and approval of […]
Press Releases
PRESS RELEASE: A “Not-For-Profit” Vaccine From Johnson & Johnson?
Washington, D.C. — Johnson & Johnson is facing new questions from Patients For Affordable Drugs after our analysis found the drug company’s promise to offer a not-for-profit COVID-19 vaccine is more than a little misleading. As Johnson & Johnson (J&J) garnered positive press for its announcement, a closer look found that based on the company’s […]
Press Releases
Drug Corporations Didn't Invest in Vaccines Until a Global Pandemic
WASHINGTON, DC — In a new review, Patients For Affordable Drugs examined the drug industry’s historic disinterest in vaccines and treatments for global pandemics like COVID-19. P4AD found that while public health experts have warned of a pandemic for years, drug corporations were uninterested in developing new drugs until it was clear that vaccines and […]
Press Releases
Statement: Public-Private Partnership to Drive COVID-19 Research Overlooks Drug Prices
WASHINGTON, DC — In response to the new NIH-led public-private partnership to accelerate COVID-19 treatments and vaccines, David Mitchell, a cancer patient and the founder of Patients For Affordable Drugs, issued the following statement: “We are glad the federal government is directing billions of taxpayer dollars to find treatments and vaccines for COVID-19. But since […]
Press Releases
Tracking COVID-19 Funds: How U.S. Taxpayers Are Investing in Vaccines and Treatments
WASHINGTON, D.C. — A new analysis by Patients For Affordable Drugs found that in one week in March, U.S. taxpayers gave more than $700 million to just three drug companies for research and development into COVID-19 vaccines and treatment. Today’s review — the first in a three-part series that will examine taxpayer investment into COVID-19 […]
Press Releases
Patients Call On Insulin Manufacturers To Respond To Covid-19 Pandemic And Lower List Prices
WASHINGTON, D.C. — With research showing that patients with diabetes have a higher mortality rate and are more likely to experience complications from COVID-19, Patients For Affordable Drugs and 63 people living with diabetes penned a letter to the Big 3 insulin manufacturers urging them to take action to lower the list prices of their […]
Press Releases
NEW VIDEO: Patient Advocate With $155k Drug Tab Raises Voice to Lower Drug Prices
WASHINGTON, D.C. — Patients For Affordable Drugs continues to elevate the voices of patients leading the fight to lower drug prices. This week, the organization will release its latest new video, “Savanna’s Story,” highlighting the $155,000 per year price the Texas college student faces. Watch the video here. Braun is a college student, Texan, and […]